Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements - Additional Information (Details)

v3.24.1.u1
Fair Value Measurements - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Jul. 16, 2021
Jul. 15, 2021
Mar. 31, 2024
Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities     $ 36,415 $ 51,289
Recurring Basis | Treasury bills        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
U.S. treasury bills with maturities less than three months     $ 5,000  
Public Warrant        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Warrant exercisable (in shares)     14,325,000  
Warrants exercise price (in dollars per share)     $ 11.50  
Warrants outstanding (in shares)     14,324,893  
Contingent earn-out liability        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Dividends, common stock     $ 0  
Contingent earn-out liability | Measurement Input, Price Volatility        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration, measurement input     85.00%  
Contingent earn-out liability | Measurement Input, Risk Free Interest Rate        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration, measurement input     4.60%  
Contingent earn-out liability | Change in control        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration, measurement input     25.00%  
Contingent earn-out liability | Measurement Input, Expected Term        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration term     1 year 10 months 24 days  
Contingently issuable common stock liability        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Dividends, common stock     $ 0  
Issuance of common stock in connection with the consummation of the PIPE Investment (in shares) 517,500 4,312,500    
Shares vested (in shares) 1,897,500      
Outstanding shares expected to vest (in shares)       1,897,500
Contingently issuable common stock liability | Measurement Input, Price Volatility        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration, measurement input     95.00%  
Contingently issuable common stock liability | Measurement Input, Risk Free Interest Rate        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration, measurement input     4.50%  
Contingently issuable common stock liability | Change in control        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration, measurement input     25.00%  
Contingently issuable common stock liability | Measurement Input, Expected Term        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Contingent consideration term     2 years 3 months 18 days